(Updates with more details from the second paragraph.)
Patterson Companies (PDCO) said Wednesday that it has agreed to be acquired by health care investment firm Patient Square Capital for $31.35 per share in cash.
The proposed transaction values Patterson at around $4.1 billion, including the refinancing of its receivables facilities, and will be financed through committed equity financing by Patient Square Equity Partners and debt financing led by Citi, UBS Investment Bank, and Wells Fargo Bank, Patterson said.
The purchase price represents a 49% premium to Patterson's 30-day volume-weighted average price as of Dec. 4, the company added.
Patterson said its board of directors, excluding President and Chief Executive Don Zurbay due to his management role, unanimously approved the transaction, which is expected to close in Q4 of the company's fiscal 2025.
The agreement includes a 40-day "go-shop" period for Patterson to seek alternative acquisition proposals. Upon completion, Patterson said it will become a privately held company and will delist from the Nasdaq Global Select Market.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。